# To Evaluate the Pharmacokinetic Interactions and Safety Between Fimasartan and Rosuvastatin

> **NCT01921946** · PHASE1 · COMPLETED · sponsor: **Boryung Pharmaceutical Co., Ltd** · enrollment: 50 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Fimasartan
- **DRUG:** Rosuvastatin

## Key facts

- **NCT ID:** NCT01921946
- **Lead sponsor:** Boryung Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2013-09
- **Final completion:** 2013-10
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2013-10-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01921946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01921946, "To Evaluate the Pharmacokinetic Interactions and Safety Between Fimasartan and Rosuvastatin". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01921946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*